In 2023 Lilly published results of its phase 2 trial for orforglipron, a once-daily oral drug which achieved up to 14.7% mean weight reduction at 36 weeks, and Pfizer has completed phase 2 trial for its oral drug danuglipron and is now optimising the formulation
and Donohoe, R
If you read labels closely, you might have noticed lip plumpers being marketed with terms like 'hot', 'cooling', 'chilli', and 'minty'
Anti-Aging and Skin Health: Some IV therapies are infused with antioxidants and nutrients that combat oxidative stress, reduce inflammation, and promote skin health, contributing to a rejuvenated and youthful appearance
coordinated workup if indicated Insulin resistance with normal HbA1c - full metabolic workup, lifestyle prioritization Preventive care screenings - weight management is part of cardiovascular risk reduction, cancer screening pacing, and overall preventive medicine Post-bariatric weight regain - coordinated with your surgical team, when appropriate Our providers Dr